Purpose

Individuals with Fragile X Syndrome show differences in how they understand and learn language from infancy. They frequently have lifelong delays in speech and language as well. In addition, they experience other auditory symptoms, including being very sensitive to certain sounds as well as being more sensitive than others to loud sounds. The underlying brain activity for sound perception and speech learning in Fragile X is not well understood, especially in the infant and toddler years. This study uses behavioral assessment of speech and language abilities, neuroimaging, and hearing tests to understand how speech and hearing are different in children with Fragile X Syndrome.

Condition

Eligibility

Eligible Ages
Between 6 Months and 26 Months
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Diagnoses of Fragile X Syndrome, Typical Development, or History of Premature Birth - able to sit independently - English is spoken at home

Exclusion Criteria

  • For all participants: no seizures in the past 6 months - For typical development group and Fragile X group: not born prior to 32 weeks gestation

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Basic Science
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Speech Sounds
Participants listen to speech sounds while the investigators measure electrical and hemodynamic changes in the brain.
  • Other: Speech discrimination
    Two different speech sounds are played at the same sound intensity.

Recruiting Locations

Cincinnati Children's Hospital
Cincinnati, Ohio 45229
Contact:
Elizabeth Smith, PhD
5135171383
elizabeth.smith3@cchmc.org

More Details

Status
Recruiting
Sponsor
Children's Hospital Medical Center, Cincinnati

Study Contact

Elizabeth Smith, PhD
5135171383
elizabeth.smith3@cchmc.org

Detailed Description

Fragile X Syndrome (FXS) is the leading monogenic cause of intellectual disability and autism and is associated with extremely high risk for early delays in speech and language. While infancy is essential for speech and language development, neural mechanisms for language impairments have been studied entirely in older children and adults with FXS. Therefore, markers for speech and language impairments are unavailable in infants and toddlers with FXS to predict severity, test potential mechanisms, and track response to intervention. The investigators have identified a hallmark brain-based phenotype of hyperresponsiveness to sounds in adolescents and adults with FXS. This fundamental alteration in cortical responses to sound could influence early language delays, but this phenotype has not been explored in infants or toddlers with FXS. Specifically, in this study the investigators will use simultaneous EEG/fNIRS during presentation of simple speech, stories, and nonspeech sounds to quantify and localize auditory hypersensitivity and neural differentiation in 30 infants and toddlers, including 15 with FXS and 15 controls. Infants will complete visits at different ages, with possible visits at 6 months, 12 months, 18 months, and 24 months, so that changes with development can be tracked over time.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.